QIPT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Quipt Home Medical Corp. (QIPT) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock is trading near its take-private transaction price of $3.65, leaving limited upside potential. Additionally, no significant trading signals or catalysts are present to suggest immediate action.
The MACD is below zero and negatively contracting, indicating weak momentum. RSI is neutral at 59.956, and moving averages are converging, suggesting no clear trend. Support and resistance levels are tight, with the current price at $3.57 near the pivot of $3.568.
The company reported strong revenue growth of 31.96% YoY in Q1 2026, and gross margin increased by 6.10% YoY to 56.38%. Analyst Richard Close raised the price target to $3.65, aligning with the take-private transaction price.
Net income dropped by -2.86% YoY, and EPS fell by -33.33% YoY. The ongoing investigation by Halper Sadeh LLC regarding the take-private transaction may create uncertainty. Limited upside potential due to the stock trading near the take-private price.
In Q1 2026, revenue increased by 31.96% YoY to $80.996M, but net income dropped to -$1.053M (-2.86% YoY), and EPS decreased to -$0.02 (-33.33% YoY). Gross margin improved to 56.38%, up 6.10% YoY.
Canaccord analyst Richard Close raised the price target to $3.65 from $2.30 and maintained a Hold rating, reflecting limited upside potential due to the take-private transaction.
